EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitNetzwerk-MetaanalyseOpen Access

Network meta-analysis of multiple doses of vonoprazan for the treatment of erosive esophagitis

Jie He iD, Yuanyuan Gao iD, Ge Bai, Jie Wang, Yongshun Sun iD

Journal of Comparative Effectiveness Research · 2023-08 · 12 (8)

DOI: 10.57264/cer-2022-0165 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Comparative Effectiveness Research, 2023-08. Verfasst von Jie He und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastrology/Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200000, China. Hauptthemen laut MEDLINE: Esophagitis, Peptic, Peptic Ulcer. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Nature Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

20 mg of vonoprazan (VPZ20) is recommended in most countries to treat erosive esophagitis (EE). Whether other doses of vonoprazan, such as 5 mg (VPZ5), 10 mg (VPZ10), 20 mg (VPZ20), and 40 mg (VPZ40) are more effective is unknown. Materials & methods: Three databases were electronically searched to identify studies published before November 2021. Network meta-analysis was performed using STATA 14.0.

Results

VPZ20 and VPZ40 were comparable to PPI, VPZ5 and VPZ10 in 4- and 8-week healing rates, and this was also detected in patients with refractory EE. All regimens resulted in similar treatment-emergent adverse events (TEAEs). However, VPZ40 ranked first for healing rate and TEAEs; however, VPZ20 ranked worst for TEAEs.

Conclusion

Different doses of VPZ are comparable in efficacy and safety, but VPZ40 may be best in both effectiveness and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophagitis, PepticPeptic UlcerHumansProton Pump InhibitorsPyrrolesTreatment OutcomeSulfonamides

Stichwörter der Autor:innen

erosive esophagitisgastroesophageal reflux diseasenetwork meta-analysisproton-pump inhibitorsvonoprazan

Substanzen

Proton Pump InhibitorsPyrroles1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamineSulfonamides

Autor:innen und Institutionen

  • Gastrology/Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200000, China.
  • Apartment of Mental disease/Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200000, Shanghai, China.
  • Oncology/Shanxi University of Traditional Chinese Medicine, Taiyuan, Shanxi, 030000, China.

ORCID-Profile: Jie He, Yuanyuan Gao, Yongshun Sun

Förderung

  • National Nature Science Foundation of China

Zitieren

APA

He, J., Gao, Y., Bai, G., Wang, J., & Sun, Y. (2023). Network meta-analysis of multiple doses of vonoprazan for the treatment of erosive esophagitis. Journal of Comparative Effectiveness Research, 12(8). https://doi.org/10.57264/cer-2022-0165

Vancouver

He J, Gao Y, Bai G, Wang J, Sun Y. Network meta-analysis of multiple doses of vonoprazan for the treatment of erosive esophagitis. Journal of Comparative Effectiveness Research. 2023;12(8). doi:10.57264/cer-2022-0165

BibTeX
@article{He2023,
  author = {He, Jie and Gao, Yuanyuan and Bai, Ge and Wang, Jie and Sun, Yongshun},
  title = {Network meta-analysis of multiple doses of vonoprazan for the treatment of erosive esophagitis},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2023},
  volume = {12},
  number = {8},
  doi = {10.57264/cer-2022-0165}
}
Kostenlos starten →